Measles Virus Fusion Protein (MV F) (AA 451-550) Antikörper (Cy7)

Produktnummer ABIN729409

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch in IF (cc) und IF (p). Er zeigt eine Reaktivität gegenüber Measles Virus und Virus.

Kurzübersicht für Measles Virus Fusion Protein (MV F) (AA 451-550) Antikörper (Cy7) (ABIN729409)

Target: Measles Virus Fusion Protein (MV F)

Reaktivität: Measles Virus, Virus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Cy7

Applikation: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Produktdetails

Bindungsspezifität: AA 451-550

Kreuzreaktivität: Virus

Kreuzreaktivität (Details): Measles virus

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from Measles virus fusion protein

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Antigendetails

Target: Measles Virus Fusion Protein (MV F)

Andere Bezeichnung: Measles Virus Fusion Protein

Substanzklasse: Viral Protein

Hintergrund:

Synonyms: Fusion glycoprotein F0, Fusion glycoprotein F1, MeV, Morbillivirus

Background: Class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (F protein) probably interacts with H at the virion surface. Upon HN binding to its cellular receptor, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between cell and virion membranes. Later in infection, F proteins expressed at the plasma membrane of infected cells could mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (By similarity).

Gen-ID: 1489800

UniProt: P69353